US Patent Issued to NeuroPace on May 20 for "Systems and methods for controlling operation of an implanted neurostimulation system based on a mapping of episode durations and seizure probability biomarkers" (California, Indiana Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,693, issued on May 20, was assigned to NeuroPace Inc. (Mountain View, Calif.).

"Systems and methods for controlling operation of an implanted neurostimulation system based on a mapping of episode durations and seizure probability biomarkers" was invented by Sharanya Arcot Desai (Sunnyvale, Calif.) and David A. Greene (Fort Wayne, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An implanted neurostimulation system is configured to sense episodes of electrographic events and determine durations of episodes. Durations of electrographic events sensed by the implanted neurostimulation system are mapped with seizure probability biomarkers derived from...